Access Bio-Rad custom antibody generation services through the Scientist.com marketplace.
A personal, no obligation quotation for a custom monoclonal antibody generation project
Tel: +49 (0) 89 80 90 95 45
Fax: +49 (0) 89 80 90 95 50
Office: Bio-Rad AbD Serotec GmbH, Campus Neuried, Anna-Sigmund-Str. 5, 82061 Neuried, Germany
Resources supporting the use of HuCAL® recombinant monoclonal antibodies
Discover the technology behind Bio-Rad’s custom recombinant antibodies.
Watch our latest video to see inside Bio-Rad’s custom antibody facility. Learn from antibody experts how your requirements for specialized custom antibodies can become a reality through the use of HuCAL technology.
How specialized antibody reagents address the challenges of CAR-T cell therapy development
Overcome the challenges of PK Assay development using TrailBlazer Antibodies
Generation of SARS-CoV-2 antibodies in multiple formats within four weeks
Recombinant antibodies with SpyTag technology
Transform your bioanalytical assay development with TrailBlazer Antibodies
Five ways to control your critical antibody reagents and avoid bioanalytical assay failure
How to improve your antibody drug development assays with anti-idiotypic antibodies
Optimize your assays using recombinant antibodies selected for desired affinity
The making of recombinant anti-idiotypic antibodies for high performance in bioanalytical assays
Dr Christian Frisch explains how we generate anti-idiotypic antibodies for bioanalytical assay development using the HuCAL recombinant antibody technology; recorded at the EBF 8th Open Meeting.
Hear how Bio-Rad’s recombinant anti-idiotypic antibodies, made using HuCAL technology, fulfill the high quality standards demanded for use in assays to support the clinical evaluation of monoclonal antibody drugs; recorded at the EBF 9th Open Meeting.
Michael Schwenkert describes how high sensitivity PK assays can be developed using specialized drug-target complex specific antibodies, avoiding the ELISA bridging format; recorded at the EBF 10th Open Meeting (Barcelona, November 2017).
Michael Schwenkert talks about challenges associated with the development of CAR-T cell therapies that can be addressed using anti-idiotypic antibodies, and explains how Bio-Rad generates custom antibodies for this application (Barcelona, November 2018).
Ulrich Mayer describes how bioanalytical scientists can address the challenges of robust, selective and sensitive PK and ADA assay development through the use of customized anti-biotherapeutic antibodies generated by Bio-Rad (Barcelona, November 2019).
Monitoring antibody immune responses against biotherapeutic drugs
Effective tools for drug monitoring assays
An accelerated approach to sensitive ADA assays
Generation and characterization of drug-target complex-specific antibodies
Faster generation of anti-drug antibodies using SpyTag technology
Anti-biotherapeutic antibody development against Ipilimumab with HuCAL PLATINUM®
Drug-target-complex specific antibodies for pharmacokinetic analysis of biotherapeutics
Characterization of anti-idiotypic antibodies for high performance in bioanalytical assays
Recombinant anti-idiotypic antibodies for antibody drug development
Human recombinant antibodies as positive controls and calibrators
Recombinant antibodies as standards for immunodiagnostic assays
How to overcome assay challenges using custom recombinant antibodies
Generation of antibodies against self-antigens using HuCAL technology
Isolation of enzyme active site-specific recombinant antibodies by guided selection
Biomarker assay development using highly specific antibodies
Generation of recombinant anti-EGF R and anti-EGF R pTyr1045 antibodies
Generation of high affinity recombinant anti-IL-6 antibodies for application in Bio-Plex® assays
Generation of high affinity recombinant antibodies for application in immuno-MRM
High-affinity antibodies for peptide enrichment immuno-MRM